AIIMS to prove stem cell therapy
AIIMS is all set to prove to the world the efficacy of its stem cell therapy conducted on heart patients.
The premier medical institute in the country is all set to prove to the world the efficacy of its stem cell therapy conducted over the last 18 months on heart patients, with the help of Positron Emission Tomography (PET) technique.
"Positron Emission Tomography is being installed at AIIMS next month, through which we will get the final proof of our work on heart patients. All the patients would be screened for finding how viable our work was and would also study various heart tissues of the patients metabolically," Dr P Venugopal, Director, AIIMS, told the agency.
"In our study, we used this therapy on 33 patients and all of them are showing positive results," he says.
Researchers at AIIMS have also conducted some pilot studies for use of stem cells in diabetics and now plan to inject these cells directly into pancreatic arteries of these patients.
"For future research, we are looking at all areas - diabetes, muscular dystrophy, cerebral palsy, other neurological disorders and Parkison's disease. The residual damage after stroke too can be minimised by injecting stem cells," Dr Venugopal said.
"We also plan to inject stem cells directly into the pancreatic arteries of patients suffering from diabetes," he says.
"Stem cell therapy can be used for all those diseases, which uptill now had no cure and patients suffering from them are bound to die - Alzheimer's, cardiac muscle end stage, liver, kidney failure. The research has come as a boon for them," he says.
"Stem cells have unlimited application. As our bodies are grown in the mothers' womb from a single cell, the stem cells have the same potential and can grow into any cell - of heart, brain, kidney, liver, etc," says Dr BG Matapurkar, consultant surgeon and researcher, Maulana Azad Medical College.